benute

Benute is a synthetic opioid analgesic and sedative that was developed in the 1960s. It is a prodrug, meaning it is inactive until metabolized in the body. Once metabolized, it is converted into its active metabolite, norbenutone, which is a potent opioid. Benute was marketed under the brand name Fentutal and was used for the management of moderate to severe pain, as well as for sedation in medical procedures.

The drug was approved for use in several countries, including the United States, but its use has been associated with serious side effects, including respiratory depression and death. In 1977, the U.S. Food and Drug Administration (FDA) issued a public health advisory warning about the potential for abuse and dependence, leading to its eventual withdrawal from the market.

Benute is no longer available for medical use, and its production has been discontinued. However, it remains of historical significance in the study of opioid pharmacology and the development of safer analgesic drugs. The experience with benute has contributed to the understanding of the risks associated with opioid analgesics and has influenced the development of more controlled and monitored prescribing practices.